Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

NCT00127270 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence

Interventions

DRUG: Darifenacin
DRUG: Darifenacin
BEHAVIORAL: Behavioral therapy

Sponsor

Novartis

Collaborators

[object Object]